Damon Runyon identifies today’s most brilliant early career scientists and funds their innovative cancer research.
- Today’s Promising Areas of Cancer Research
- What is Cancer?
- A Broken Pipeline?
A Generation of Science at Risk
- ARISE Report
Early Career Scientists and High-Risk, High Reward Research - American Academy of Arts and Sciences
- Why We’re Losing the War on Cancer (And How To Win It)
Clifton Leaf - Fortune Magazine
January 1, 2009 > Protein could be target for head and neck squamous cell carcinoma
Christine H. Chung, MD (Damon Runyon-Lilly Clinical Investigator '05-'10) of the Vanderbilt University School of Medicine, Nashville, and colleagues, identified a critical function of Protein Kinase Cα (PKCα) and microRNA miR-15a in regulating tumor cell growth in head and neck squamous cell carcinoma (SCCHN), a type of head and neck cancer. The researchers demonstrated that agents that block PKCα decrease tumor growth in animal models, indicating that this protein may be a promising target for treatment of SCCHN. These findings were published in the journal Cancer Research.